R F INDUSTRIES LTD — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that R F INDUSTRIES LTD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Oct 31, 2019 | $55.33M | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | $50.20M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $22.98M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $30.24M | Jan 24, 2018 |
| FY2016 | Oct 31, 2015 | $30.91M | Jan 27, 2017 |
| FY2015 | Oct 31, 2014 | $23.12M | Jan 28, 2016 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $30.96M | Jan 24, 2018 |
| FY2017 | Oct 31, 2016 | $30.24M | Jan 24, 2018 |
| FY2016 | Oct 31, 2015 | $30.91M | Jan 27, 2017 |
| FY2015 | Oct 31, 2014 | $23.12M | Jan 28, 2016 |
| FY2014 | Oct 31, 2013 | $36.63M | Jan 29, 2015 |
| FY2013 | Oct 31, 2012 | $27.69M | Jan 17, 2014 |
| FY2012 | Oct 31, 2011 | $19.43M | Jan 22, 2013 |
| FY2011 | Oct 31, 2010 | $16.32M | Jan 27, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $26.74M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $18.87M | Jan 14, 2026 |
| FY2023 | Oct 31, 2023 | $19.54M | Jan 29, 2024 |
| FY2024 | Oct 31, 2022 | $19.54M | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $17.77M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $11.57M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $15.64M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $17.10M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $6.99M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $8.46M | Jan 24, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $75.0K | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | ($6.60M) | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | ($3.08M) | Jan 21, 2025 |
| FY2024 | Oct 31, 2022 | ($3.08M) | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $6.18M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | ($81.0K) | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $3.52M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $5.85M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $382.0K | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | ($4.09M) | Jan 24, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.79M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | ($2.82M) | Jan 14, 2026 |
| FY2023 | Oct 31, 2023 | ($3.80M) | Jan 29, 2024 |
| FY2024 | Oct 31, 2022 | ($3.80M) | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $4.42M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | ($403.0K) | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $4.46M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $7.45M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $203.0K | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | ($4.69M) | Jan 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.98M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $2.78M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $3.15M | Jan 21, 2025 |
| FY2024 | Oct 31, 2022 | $3.15M | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $1.48M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $1.99M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $1.47M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $1.48M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $824.0K | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $747.0K | Jan 24, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $21.97M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $18.91M | Jan 14, 2026 |
| FY2023 | Oct 31, 2023 | $20.18M | Jan 29, 2024 |
| FY2024 | Oct 31, 2022 | $20.18M | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $11.87M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $9.98M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $9.71M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $8.17M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $5.96M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $9.56M | Jan 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.58M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $3.17M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $4.19M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $2.89M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | ($3.12M) | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $4.55M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | ($2.71M) | Dec 29, 2020 |
| FY2017 | Oct 31, 2017 | $1.60M | Jan 24, 2018 |
| FY2017 | Oct 31, 2016 | ($1.27M) | Jan 24, 2018 |
| FY2016 | Oct 31, 2015 | $168.0K | Jan 27, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $235.0K | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $738.0K | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $2.48M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $2.68M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $227.0K | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $235.0K | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $538.0K | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $266.0K | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $171.0K | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $384.0K | Jan 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $73.05M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $71.05M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $82.28M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $89.57M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $49.65M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $40.82M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $37.70M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $32.50M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $25.06M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $25.84M | Jan 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $37.84M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $36.98M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $42.52M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $47.70M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $10.05M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $8.76M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $6.17M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $4.72M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $3.72M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $4.45M | Jan 24, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $35.20M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $34.07M | Jan 14, 2026 |
| FY2025 | Oct 31, 2023 | $39.76M | Jan 14, 2026 |
| FY2024 | Oct 31, 2022 | $41.87M | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | $39.60M | Jan 29, 2024 |
| FY2023 | Oct 31, 2020 | $32.06M | Jan 24, 2023 |
| FY2021 | Oct 31, 2019 | $31.53M | Jan 14, 2022 |
| FY2020 | Oct 31, 2018 | $27.78M | Dec 29, 2020 |
| FY2018 | Oct 31, 2017 | $21.34M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $21.39M | Jan 24, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $8.09M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $8.09M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $8.09M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $8.09M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $2.47M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $2.47M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $1.34M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $1.34M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $1.34M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $3.22M | Jan 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $7.05M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $6.97M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $13.57M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $16.65M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $15.20M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $9.02M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $9.49M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $6.72M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $1.60M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $1.93M | Jan 24, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $5.08M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $839.0K | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $4.90M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $4.53M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $13.05M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $15.80M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $12.54M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $16.33M | Dec 20, 2019 |
| FY2019 | Oct 31, 2017 | $5.21M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $5.26M | Dec 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0 | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | 0 | Jan 21, 2025 |
| FY2024 | Oct 31, 2022 | 0 | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | 0 | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | 0 | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | 0 | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | 0 | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | 0 | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | 0 | Jan 24, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0 | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | 0 | Jan 21, 2025 |
| FY2024 | Oct 31, 2022 | 0 | Jan 21, 2025 |
| FY2023 | Oct 31, 2021 | 0 | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | 0 | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | 0 | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | 0 | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | 0 | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | 0 | Jan 24, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 10.71M | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | 10.54M | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | 10.34M | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | 10.19M | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | 10.06M | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | 9.81M | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | 9.46M | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | 9.29M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | 8.87M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | 8.84M | Jan 24, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $0 | Jan 14, 2026 |
| FY2025 | Oct 31, 2024 | $0 | Jan 14, 2026 |
| FY2024 | Oct 31, 2023 | $0 | Jan 21, 2025 |
| FY2023 | Oct 31, 2022 | $0 | Jan 29, 2024 |
| FY2023 | Oct 31, 2021 | $0 | Jan 24, 2023 |
| FY2021 | Oct 31, 2020 | $388.0K | Jan 14, 2022 |
| FY2020 | Oct 31, 2019 | $748.0K | Dec 29, 2020 |
| FY2019 | Oct 31, 2018 | $730.0K | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $707.0K | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $1.14M | Jan 24, 2018 |